Dear Doctors: I was recently diagnosed with Paget’s disease after suffering fatigue symptoms and muscle soreness in my neck, pelvic and lower-leg areas. I am sore and lethargic upon waking up in the ...
The authors do not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and have disclosed no relevant affiliations beyond their ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA approved ...
The interplay between bone and cardiovascular systems represents a dynamic and rapidly expanding field of biomedical research. Scientific advances have ...
Ultragenyx Pharmaceutical (NASDAQ:RARE) fell ~23%, and Mereo BioPharma (NASDAQ:MREO), its partner for bone disorder therapy UX143 (setrusumab), lost ~36% in the premarket on Thursday after the ...
Ultragenyx Pharmaceutical and Mereo BioPharma said their two Phase 3 trials for setrusumab to treat rare bone disorder osteogenesis imperfecta, didn't meet their main goal of reducing fracture rates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback